ArticleTranslational oncology2026
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer.
Angela Lamarca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.